Ortho-Preserve
Henrico, US · Founded 2021 · 1 known investors
OrthoPreserve is developing an artificial meniscus implant intended to relieve knee pain following meniscus injury, restore joint function, and prevent degeneration leading to arthritis. The company operates in the orthopedic medical device field.
HealthtechMedical Devices
Founders & leadership
JS
Jonathan SchwartzExecutive Officer, Director
CK
Cyrus KumpExecutive Officer, Director
Investors · 1
Reported raises · per SEC filings
Form D private placements▶$157KraisedDec 2025 · 3 investors · Other Health CareRule 506(b)
▶$157KraisedDec 2025 · 3 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Jonathan William SchwartzExecutive Officer, Director
- David Max GuillotDirector
- Cyrus Scott KumpExecutive Officer, Director
- Offering amount
- $2M
- Amount sold
- $157K
- First sale
- Dec 2025
- Incorporated
- Corporation, Delaware, 2025
- Federal exemptions
- 06b
▶$50KraisedOct 2024 · 2 investors · Other Health CareRule 506(b)
▶$50KraisedOct 2024 · 2 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Jonathan SchwartzExecutive Officer, Director
- Cyrus KumpExecutive Officer, Director
- Offering amount
- $2M
- Amount sold
- $50K
- First sale
- Oct 2024
- Incorporated
- Corporation, Virginia, 2021
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Non-dilutive funding · 1 SBIR/STTR award
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2023 | $303.9K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.